| Year |
Citation |
Score |
| 2023 |
Knowles SJ, Stafford AM, Zaman T, Angara K, Williams MR, Newbern JM, Vogt D. Distinct hyperactive RAS/MAPK alleles converge on common GABAergic interneuron core programs. Development (Cambridge, England). 150. PMID 37254876 DOI: 10.1242/dev.201371 |
0.454 |
|
| 2021 |
Canales CP, Estes ML, Cichewicz K, Angara K, Aboubechara JP, Cameron S, Prendergast K, Su-Feher L, Zdilar I, Kreun EJ, Connolly EC, Seo JM, Goon JB, Farrelly K, Stradleigh TW, et al. Sequential perturbations to mouse corticogenesis following in utero maternal immune activation. Elife. 10. PMID 33666173 DOI: 10.7554/eLife.60100 |
0.457 |
|
| 2020 |
Wundrach D, Martinetti LE, Stafford AM, Bilinovich SM, Angara K, Prokop JW, Crandall SR, Vogt D. A Human Variant Screening Platform in Gabaergic Cortical Interneurons for Genotype to Phenotype Assessments. Frontiers in Molecular Neuroscience. 13: 573409. PMID 33071758 DOI: 10.3389/Fnmol.2020.573409 |
0.502 |
|
| 2020 |
Angara K, Pai EL, Bilinovich SM, Stafford AM, Nguyen JT, Li KX, Paul A, Rubenstein JL, Vogt D. deletion results in depletion of the transcription factor and a specific loss of parvalbumin cortical interneurons. Proceedings of the National Academy of Sciences of the United States of America. PMID 32123116 DOI: 10.1073/Pnas.1915458117 |
0.603 |
|
| 2020 |
Achyut BR, Zhang H, Angara K, Mivechi NF, Arbab AS, Ko L. Oncoprotein GT198 Vaccination Delays Tumor Growth in MMTV-PyMT Mice. Cancer Letters. PMID 32061755 DOI: 10.1016/J.Canlet.2020.02.005 |
0.342 |
|
| 2019 |
Malik R, Pai EL, Rubin AN, Stafford AM, Angara K, Minasi P, Rubenstein JL, Sohal VS, Vogt D. Tsc1 represses parvalbumin expression and fast-spiking properties in somatostatin lineage cortical interneurons. Nature Communications. 10: 4994. PMID 31676823 DOI: 10.1038/S41467-019-12962-4 |
0.605 |
|
| 2019 |
Rashid MH, Borin TF, Ara R, Angara K, Cai J, Achyut BR, Liu Y, Arbab AS. Differential in vivo biodistribution of I-labeled exosomes from diverse cellular origins and its implication for theranostic application. Nanomedicine : Nanotechnology, Biology, and Medicine. 102072. PMID 31376572 DOI: 10.1016/J.Nano.2019.102072 |
0.321 |
|
| 2019 |
Borin TF, Ali S, Angara K, Rashid M, Myers S, Chawla D, Ara R, Lebedyeva I, Achyut BR, Arbab AS. Abstract 127: CYP4A11 overexpression increases aggressiveness in glioblastoma and breast cancer Cancer Research. 79: 127-127. DOI: 10.1158/1538-7445.Am2019-127 |
0.394 |
|
| 2019 |
Rashid MH, Borin TF, Ara R, Angara K, Bhagelu A, Cai J, Liu Y, Arbab AS. Abstract 1139: CD206 positive M2-macrophage targeting engineered exosomes as a potential diagnostic and therapeutic tool Cancer Research. 79: 1139-1139. DOI: 10.1158/1538-7445.Am2019-1139 |
0.319 |
|
| 2018 |
Angara K, Borin TF, Rashid MH, Lebedyeva I, Ara R, Lin PC, Iskander A, Bollag RJ, Achyut BR, Arbab AS. CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma. Neoplasia (New York, N.Y.). 20: 1070-1082. PMID 30236892 DOI: 10.1016/J.Neo.2018.08.011 |
0.369 |
|
| 2018 |
Rashid MH, Borin T, Angara K, Ara R, Bhagelu A, Arbab A. Abstract LB-368: Determining and characterizing differential biodistribution of tumor derived exosomes by non-invasive nuclear imaging Tumor Biology. DOI: 10.1158/1538-7445.Am2018-Lb-368 |
0.314 |
|
| 2017 |
Borin TF, Angara K, Rashid MH, Achyut BR, Arbab AS. Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis. International Journal of Molecular Sciences. 18. PMID 29292756 DOI: 10.3390/Ijms18122661 |
0.39 |
|
| 2017 |
Arbab AS, Rashid MH, Angara K, Borin TF, Lin PC, Jain M, Achyut BR. Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma. International Journal of Molecular Sciences. 18. PMID 29258180 DOI: 10.3390/Ijms18122732 |
0.314 |
|
| 2017 |
Achyut BR, Angara K, Jain M, Borin TF, Rashid MH, Iskander ASM, Ara R, Kolhe R, Howard S, Venugopal N, Rodriguez PC, Bradford JW, Arbab AS. Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth. Scientific Reports. 7: 13754. PMID 29062041 DOI: 10.1038/S41598-017-14079-4 |
0.398 |
|
| 2017 |
Zhang L, Wang Y, Rashid MH, Liu M, Angara K, Mivechi NF, Maihle NJ, Arbab AS, Ko L. Malignant pericytes expressing GT198 give rise to tumor cells through angiogenesis. Oncotarget. 8: 51591-51607. PMID 28881671 DOI: 10.18632/Oncotarget.18196 |
0.408 |
|
| 2017 |
Angara K, Borin TF, Arbab AS. Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma. Translational Oncology. 10: 650-660. PMID 28668763 DOI: 10.1016/J.Tranon.2017.04.007 |
0.353 |
|
| 2017 |
Zhang L, Wang Y, Rashid MH, Liu M, Angara K, Mivechi NF, Maihle NJ, Arbab AS, Ko L. Malignant pericytes expressing GT198 give rise to tumor cells through angiogenesis. Oncotarget. PMID 28624783 DOI: 10.18632/oncotarget.18196 |
0.306 |
|
| 2017 |
Borin TF, Shankar A, Angara K, Rashid MH, Jain M, Iskander A, Ara R, Lebedyeva I, Korkaya H, Achyut BR, Arbab AS. HET0016 decreases lung metastasis from breast cancer in immune-competent mouse model. Plos One. 12: e0178830. PMID 28609459 DOI: 10.1371/Journal.Pone.0178830 |
0.354 |
|
| 2017 |
Jain M, Gamage NH, Alsulami M, Shankar A, Achyut BR, Angara K, Rashid MH, Iskander A, Borin TF, Wenbo Z, Ara R, Ali MM, Lebedyeva I, Chwang WB, Guo A, et al. Intravenous Formulation of HET0016 Decreased Human Glioblastoma Growth and Implicated Survival Benefit in Rat Xenograft Models. Scientific Reports. 7: 41809. PMID 28139732 DOI: 10.1038/Srep41809 |
0.363 |
|
| 2017 |
Borin TF, Angara K, Rashid M, Shankar A, Iskander A, Ara R, Jain M, Achyut BR, Arbab AS. Abstract 1043: CSF-1R inhibitor prevented pre-metastatic lung niches in metastatic mammary tumor Cancer Research. 77: 1043-1043. DOI: 10.1158/1538-7445.Am2017-1043 |
0.318 |
|
| 2016 |
Shankar A, Jain M, Lim MJ, Angara K, Zeng P, Arbab SA, Iskander A, Ara R, Arbab AS, Achyut BR. Anti-VEGFR2 driven nuclear translocation of VEGFR2 and acquired malignant hallmarks are mutation dependent in glioblastoma. Journal of Cancer Science & Therapy. 8: 172-178. PMID 28149448 DOI: 10.4172/1948-5956.1000410 |
0.393 |
|
| 2016 |
Angara K, Rashid MH, Shankar A, Ara R, Iskander A, Borin TF, Jain M, Achyut BR, Arbab AS. Vascular mimicry in glioblastoma following anti-angiogenic and anti-20-HETE therapies. Histology and Histopathology. 856. PMID 27990624 DOI: 10.14670/Hh-11-856 |
0.395 |
|
| 2016 |
Shaaban S, Alsulami M, Arbab SA, Ara R, Shankar A, Iskander A, Angara K, Jain M, Bagher-Ebadian H, Achyut BR, Arbab AS. Targeting Bone Marrow to Potentiate the Anti-Tumor Effect of Tyrosine Kinase Inhibitor in Preclinical Rat Model of Human Glioblastoma. International Journal of Cancer Research. 12: 69-81. PMID 27429653 DOI: 10.3923/Ijcr.2016.69.81 |
0.347 |
|
| 2016 |
Achyut BR, Shankar A, Jain M, Angara K, Iskander A, Ara R, Arbab AS. Abstract 252: CXCL7-CXCR2 axis as a novel prognostic factor in myeloid cell associated glioblastoma Cancer Research. 76: 252-252. DOI: 10.1158/1538-7445.Am2016-252 |
0.377 |
|
| 2015 |
Achyut BR, Shankar A, Iskander AS, Ara R, Angara K, Zeng P, Knight RA, Scicli AG, Arbab AS. Bone marrow derived myeloid cells orchestrate antiangiogenic resistance in glioblastoma through coordinated molecular networks. Cancer Letters. PMID 26404753 DOI: 10.1016/J.Canlet.2015.09.004 |
0.41 |
|
| 2015 |
Jain M, Achyut B, Shankar A, Angara K, Iskander A, Arbab AS. Abstract B30: MicoRNA mediated regulation of antiangiogenic resistance in glioblastoma Brain. 75. DOI: 10.1158/1538-7445.Brain15-B30 |
0.334 |
|
| 2015 |
Achyut BR, Shankar A, Iskander A, Ara R, Angara K, Knight R, Scicli A, Arbab A. Abstract A23: Bone marrow derived myeloid cells orchestrate resistance to antiangiogenic therapy in novel chimeric mouse model of glioblastoma Brain. 75. DOI: 10.1158/1538-7445.Brain15-A23 |
0.397 |
|
| Show low-probability matches. |